NMG
MRK icon

New Millennium Group’s Merck MRK Stock Holding History

New Millennium Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4
Closed -$336 – 483
2025
Q3 		$336 Sell
4
-445
-99% -$36.7K ﹤0.01% 390
2025
Q2 		$35.6K Buy
449
+2
+0.4% +$159 0.02% 113
2025
Q1 		$40.1K Sell
447
-6
-1% -$560 0.03% 102
2024
Q4 		$45.1K Sell
453
-10,713
-96% -$1.1M 0.03% 97
2024
Q3 		$1.27M Buy
11,166
+10,723
+2,421% +$1.27M 0.82% 28
2024
Q2 		$54.9K Buy
+443
New +$57.1K 0.04% 92
2024
Q1 		– Sell
-480
Closed -$52.3K – 270
2023
Q4 		$52.3K Buy
480
+6
+1% +$623 0.05% 96
2023
Q3 		$48.8K Buy
474
+35
+8% +$3.77K 0.04% 81
2023
Q2 		$50.6K Sell
439
-8
-2% -$908 0.05% 88
2023
Q1 		$47.6K Sell
447
-7
-2% -$756 0.05% 101
2022
Q4 		$50.4K Buy
454
+67
+17% +$6.85K 0.05% 96
2022
Q3 		$33K Buy
387
+1
+0.3% +$89 0.04% 113
2022
Q2 		$35K Buy
+386
New +$34.2K 0.04% 113

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

New Millennium Group's MRK Position: Q4 2025 in Review

New Millennium Group sold out of Merck (MRK) in Q4 2025, closing a stake of 4 shares — an estimated $336 sold.

New Millennium Group first reported a position in MRK in Q2 2022 and held it in 13 quarters. The position peaked at $1.27M in Q3 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • New Millennium Group reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • New Millennium Group sold 4 Merck shares in Q4 2025, an estimated $336.
  • New Millennium Group first reported a position in Merck in Q2 2022 and held it in 13 quarters.
  • New Millennium Group's Merck position peaked at $1.27M in Q3 2024.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.